Pyrrolidine could specifically target the cytosolic phospholipase A2 (cPLA2α) along with EGFR antibody and offer better targeting specifically to the tumour site, resulting in a higher uptake of the nanorattles than non-targeted nanorattles [199]. The gene discussed is EGFR; the disease is neoplasm.